It is even more interesting to me knowing the first CRE (Carbapenem-resistant Enterobacteriaceae [cdc.gov]) clearly arose in India.
Funny thing was the response of Indian politicians was that naming of the NDM-1 resistance factor was "malicious slander". The acronym of course standing for New Delhi Metallo-beta-lactamase. I happen to agree that geographic and ethnic names should no longer be used for disease entities, but nationalistic outrage is not a useful response to a problem.
but the reasons weren't clear to me and I just naively assumed it was a random mutation. India, also according to to that same paper has quite a problem with antibiotic resistance which one wouldn't expect as there isn't so much of a problem with antibiotic overuse as there seems to be in the West.
Don't be so sure of that, when antibiotics are (or maybe were until recently) common non-prescription OTC products in India and other parts of south and south-east Asia, and often much cheaper than in the West.